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Abstract: Integrative cancer biology research relies on a variety of data-driven computational modeling and simulation 
methods and techniques geared towards gaining new insights into the complexity of biological processes that are of critical 
importance for cancer research. These include the dynamics of gene-protein interaction networks, the percolation of sub-
cellular perturbations across scales and the impact they may have on tumorigenesis in both experiments and clinics. Such 
innovative ‘systems’ research will greatly beneﬁ  t from enabling Information Technology that is currently under develop-
ment, including an online collaborative environment, a Semantic Web based computing platform that hosts data and model 
repositories as well as high-performance computing access. Here, we present one of the National Cancer Institute’s re-
cently established Integrative Cancer Biology Programs, i.e. the Center for the Development of a Virtual Tumor, CViT, 
which is charged with building a cancer modeling community, developing the aforementioned enabling technologies and 
fostering multi-scale cancer modeling and simulation.
Keywords: Cancer; complexity; systems biology; multi-scale computational tumor modeling; semantic layered research 
platform; digital model repository.
Background
The completion of the Human Genome Project catalyzed a systems view of biomedicine which may 
well have a dramatic impact on 21st century’s life sciences all together (e.g. Deisboeck T.S. and Kresh 
J.Y., 2006). The concept, attributed to Aristotle, that “the whole is more than the sum of its parts” 
suggests that dissecting an organism, tissue or cell into ever smaller monomers and hoping to be able 
to piece it back together afterwards will not work if the underlying mechanisms are anything but linear 
and involve dynamic relationships. While systems theory per se is hardly new (see e.g. seminal work 
by Bertalanffy v. L., 1968) based on some pioneering yet rather theoretical studies on complex systems 
in biology (e.g. Kauffman S.A., 1993) the notion of systems biology as the research approach that inte-
grates biology, medicine, computation and technology to comprehend biological information processing 
has recently been embraced also by mainstream science (e.g. Ideker et al. 2001; Kitano, 2002). Conse-
quently, this has led to a wave of academic, corporate and governmental efforts in this emerging ﬁ  eld. 
Already at this nascent stage it has become abundantly clear, however, that the transition from classic 
reductionism driven biomedical science to a systems level understanding of biological processes requires 
more than access to high-performance computing only. Rather, it needs a new understanding of how 
multi-scaled biological systems have to be investigated with an approach that integrates computation 
and experiment and, ultimately, in the case of disease processes, how they can be diagnosed and 
treated—as systems. 
If a tumor is thought of as a dynamic self-organizing biosystem, one can argue that cancer is an almost 
ideal case to apply the considerable strengths of this new systems biology concept. This is not only 
because we are still far from deciphering the complexity of all the factors involved in tumorigenesis 
but also since the countless experimental and clinical studies devoted to it continue to generate an ever 
growing amount of disparate data with little chance of connecting the ‘dots’ using conventional Cancer Informatics 2007:5 2
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scientiﬁ  c approaches only. There is no doubt then 
that innovative computational modeling and simu-
lation, in conjunction with appropriately designed 
experiments, will rapidly become a valuable if not 
crucial tool for this new scientiﬁ  c path in cancer 
biology. Speciﬁ  cally, cutting edge multi-scale 
computational modeling will be able (a) to help 
generate experimentally testable hypotheses, (b) 
to integrate diverse data, and ultimately, (c) to 
predict outcome also for clinical purposes. 
Currently, mechanistic dynamical simulations and 
inferential data mining constitute the two main 
approaches in interdisciplinary cancer systems 
biology research with signiﬁ  cant progress. (1) For 
instance, molecular pathway simulation has shown 
promise exempliﬁ  ed through the work by Araujo 
et al. (2005) who have developed a mathematical 
model to investigate combination therapy with 
kinase inhibitors by building upon theoretical 
studies of the epidermal growth factor receptor 
(EGFR) pathway (Kholodenko et al. 1999). 
Another example is Athale et al. (2005, 2006) who, 
based on previous works by Mansury and 
Deisboeck (2003, 2004), have modeled a proposed 
cellular phenotypic switching mechanism also in 
the EGFR signaling pathway. Most recently, Zhang 
et al. (2007) have then extended this work in order 
to simulate the dynamics of EGFR gene-protein 
interaction proﬁ  les, alternating cell phenotypes and 
emergent multi-cellular patterns with a three 
dimensional agent-based multi-scaled model 
(Figure 1). (2) On the other hand, because it is now 
possible to extract knowledge from large-scale data 
sets employing advanced data mining techniques 
(Khalil and Hill, 2005), progress has been made in 
detecting patterns and correlations in the data that 
lead to new hypotheses about possible interactions 
such as on the protein-protein and gene-protein 
level (e.g. Yeger-Lotem et al. 2004). It is thus a 
reasonable goal to combine these two promising 
paths in the future. 
Nonetheless, despite, or more accurately, 
precisely because of the signiﬁ  cant progress made, 
several challenges for the ﬁ  eld have become 
apparent as well. That is, the absence of a cancer 
modeling dedicated, collaborative community or 
network has led to a lack of shared standards or 
even guidelines let alone unifying platforms to 
archive, exchange and integrate the many distinct 
computational and mathematical models that have 
been and are being developed. This inevitably led 
to redundancy in some cases where multiple 
models on for instance ‘cell migration’ have been 
developed over the years whereas other tumor 
characteristics have received far less attention. 
Overall, the result is a diminished impact of the 
modeling ﬁ  eld on experimental cancer research 
and a loss of potentially valuable time for clinical 
studies. Therefore, particularly for projects that 
exceed the capacities of a single team, access to 
distributed scientiﬁ  c and technical expertise, 
exchange of knowledge and sharing of biomedical 
data, modeling algorithms and analysis tools 
appear to be most critical. 
To address these issues and to advance the ﬁ  eld 
of cancer systems biology, the National Cancer 
Institute, NCI, has recently established the Integra-
tive Cancer Biology Program, ICBP (URL: http://
icbp.nci.nih.gov/). One of these nine ICBPs is the 
Center for the Development of a Virtual Tumor 
(CVIT) at the Massachusetts General Hospital in 
Boston. In the following section we brieﬂ  y introduce 
Figure 1. Multi-Scale Modeling. 3D snapshots of a virtual brain tumor at three consecutive time points (left to right), from Zhang et al. 
(2007). Blue color represents proliferating tumor cells, while red depicts migratory, green quiescent and grey dead tumor cells. At an early 
stage the proliferative tumor core appears to be completely surrounded by a cloud of migratory cells, at a later time point, however, a more 
heterogeneous picture emerges where ultimately a ‘tip’-population of migratory cells can be found adjacent to the location of a nutrient source 
(top right quadrant, not shown).Cancer Informatics 2007:5 3
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CViT’s mission and describe the technical infra-
structure that it is currently developing in collabo-
ration with IBM’s Advanced Internet 
Technology.
Introducing CViT
CViT’s mission is threefold: (1) to establish a 
community of investigators with expertise in the 
biomedical, the computational and the mathemat-
ical aspects of cancer research, and to build the 
infrastructure to enable the group’s sustained 
growth; (2) to develop a curated Digital Model 
Repository for model archive and exchange; and 
(3) to advance work towards a multi-scale 
modeling platform en route to a modeling tool-kit 
for cancer research. This section will brieﬂ  y intro-
duce several major features of CViT, such as the 
buildup of an online community, the development 
of the digital model repository and its underlying 
Semantic Web based research platform, as well as 
a how CViT envisions to process ‘knowledge 
integrated’ modeling.
Building a Cancer Modeling
Community: ‘CViT.org’
Cancer research has always been an international 
enterprise with pockets of critical expertise being 
developed at numerous sites all over the world and 
thus now, more so than ever, large-scale consortium 
projects have to go beyond institutional boundaries 
to accomplish a set task that would otherwise 
exceed the resources available at a single site. Given 
the fact that this entails setup and management
of long-distance collaborations that also cross 
multiple disciplines, a new more ﬂ  exible collab-
orative environment has to be created. CViT has 
built such a user-friendly online platform, CViT.
org (URL: http://www.cvit.org) that employs a 
username & password-protected ‘wiki’-type envi-
ronment to post and discuss content (Figure 2,
left). A relatively large portion of the regularly 
updated information such as researcher proﬁ  les 
(Figure 2, right), resources, tutorials and software 
tools, is already publicly-accessible as part of 
CViT’s commitment to community outreach. For 
the continuously growing CViT group of investiga-
tors which includes scientists from dozens of 
institutions around the world, CViT.org provides 
its participating investigators a number of advanced 
tools to rapidly communicate, thus facilitating 
dissemination of knowledge and fostering 
collaborations: (1) CViT.org offers “digital note-
books” or blogs such as “Ask the Expert” that have 
investigators present (on the basis of their PubMed-
linked abstracts) one of their recent publications 
to the group, thereby soliciting feedback and thus 
setting up a lively discussion forum (Figure 3, left). 
Another blog, “CViT Recommends” is focused 
on suggestions and recommendations of useful 
information, including links to up-to-date reviews 
and upcoming meetings relevant to the ﬁ  eld. 
(2) Secondly, really simple syndication (RSS) is a 
document speciﬁ  cation that gives users the power 
to collect and organize Web-based news and infor-
mation in a more efﬁ  cient manner. CViT RSS 
feeds are intended to encourage CViT members to 
participate in ongoing discussions within CViT and 
to facilitate access to and dissemination of cancer 
Figure 2. CViT Home Page (left) and Investigator Proﬁ  les (right).Cancer Informatics 2007:5 4
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Semantic Layered Research Platform is primarily 
based on GRID and Semantic Web
1 technologies 
and concepts (Neumann, 2005). In particular 
SLRP provides a central database for data repre-
sented in the Resource Description Framework 
(RDF)
2, a highly ﬂ  exible method of representing 
data conforming to practically any schema. All 
data and system objects are named using Life 
Science Identiﬁ  ers (LSID’s)
3 an industry stan-
dard for uniquely naming and thereby identifying 
any digital artifact. LSID’s provide a handle by 
which that object may be later retrieved and a 
unique key by which meta-data about that object 
or its relationship to other objects may be attached 
or retrieved. GRID technologies provide a systems 
management framework for the automatic deploy-
ment and tending of software systems and applica-
tions for compute and data intensive tasks in large 
clusters of computers sometimes deployed over a 
wide area. Multi-scale modeling (i.e. combining 
molecular, microscopic and macroscopic data 
levels) is such a potentially very data intense yet 
most promising tool for cancer systems biology 
(for an example, see Figure 1). CViT not only will 
support this type of approach through KIM but 
also will deposit such algorithms and their simula-
tion results in the Digital Model Repository (see 
below). 
modeling-focused, public information. Currently, 
the site provides news feeds on activity within its 
own blogs (Figure 3, right), on cancer research 
and, more generally, science news as well as on 
peer-reviewed literature relevant to cancer 
modeling efforts. (3) Thirdly, CViT.org broadcasts 
news, announcements and notiﬁ  cations using its 
mail list server to its membership as well as to the 
computational biology groups of the entire ICBP. 
(4) Lastly, an annotation system (Figure 4) 
provided by IBM makes it convenient for CViT’s 
members to annotate research documents in a 
variety of formats such as MS Word, PDF and 
others. This enables capture, collection, manage-
ment, access and exchange of any such annotations 
across the distributed teams.
Knowledge Integrated Modeling  
and Semantic Layered Research
Platform Prototype 
CViT’s Digital Model Repository (below) will 
itself be part of a wider application system 
currently named Knowledge-Integrate-Modeling 
(KIM), which is a custom application designed to 
support systems biology research. KIM in turn is 
being constructed on IBM’s prototype Semantic 
Layered Research Platform (SLRP). The 
Figure 3. CViT Blog (left) and RSS Feeds (right).
1Berners-Lee,T., Hendler, J., Lassila, O. (2001) The Semantic Web, Scientiﬁ  c American, May 2001 (URL: http://www.scientiﬁ  camerican.com/article.
cfm?articleID=00048144-10D2-1C70-84A9809EC588EF21&catID=2).
2Miller E, Swick R, Brickley D (2003) ‘W3C Resource Description Framework (RDF)’ (URL:http://www.w3c.org/RDF/).
3EBI, I3C, IBM (2003) ‘Life Science Identiﬁ  ers RFP Response Revised Joint Submission’, Object Management Group Document lifesci/03-10-01 
(URL: http://www.omg.org/cgi-bin/doc?lifesci/2003-10-01).Cancer Informatics 2007:5 5
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The SLRP platform will provide application 
services to: (1) Connect a CViT researcher’s desktop 
directly to the powerful databases in which all 
research information collected by a collaborative 
research effort is held along with its associated 
semantic linkages to other data items as well as the 
meta-data that provides each piece of stored infor-
mation with a context. (2) Enable wide area collab-
orations as characteristic for CViT by allowing the 
sharing of any data object in the system along with 
its semantic context, linkages and meta-data, thus 
allowing an interconnected web of information to 
easily be communicated between collaborators. (3) 
Allow the structured annotation of any object in the 
system, such as an area of a microscopy or MR-
image, or a parameter in an experimental result, 
whether it be to add additional meta-data or simply 
to note a semantic relationship between stored 
objects. (4) Provide interfaces to the GRID compute 
platform where models or digital experiments can 
be executed by the assembly and execution of work-
ﬂ  ows representing digital experiments by end-user 
researchers, without the need for a thorough 
technical understanding of the sophisticated 
computer systems involved. (5) Provide a visual 
interface for the integrated viewing and annotating 
of all information associated with and created by a 
research effort. (6) Provide a collaborative environ-
ment designed for the creation, debugging & main-
tenance of the source code modules associated with 
a research effort that requires signiﬁ  cant computer 
aided modeling, simulation and data intensive 
computing. The latter is of particular importance for 
the DMR.
CViT researchers using the KIM application 
will be provided with a “Biologists Workbench” 
application program that can be customized to aid 
in the tasks that scientist carries out in his/her day 
to day work and collaborations with colleagues. 
This application will be based on the Eclipse 
Framework (URL:   http://www.eclipse.org), an 
open source, cross-platform, Integrated Develop-
ment Environment that is now also being used to 
create regular end-user applications. The Eclipse 
Framework already provides a great deal of support 
for code developers including source code editors, 
source code repository integration, viewers and 
debuggers. Through the addition of SLRP compo-
nents for annotation and connectivity to the central 
SLRP data stores and custom Eclipse Perspectives 
(a perspective is a mechanism for extending the 
Eclipse visual framework) for tasks like biomedical 
image manipulation and comparison, wide-area 
collaboration, views for clustering of related data 
objects or editing information in PDF, spreadsheet, 
word processing documents or web formats, and 
for creating or reviewing digital experiment work 
ﬂ  ow assemblers, this environment will provide an 
excellent single desktop work space for the CViT 
community (Figure 5).
The Digital Model Repository (DMR) 
The Digital Model Repository will utilize the 
Concurrent Versioning System (CVS; URL: 
http://ximbiot.com/cvs/wiki/index.php)
 as the 
primary source code control system. CVS enjoys 
wide support from development tooling in general 
and the Eclipse IDE in particular. It will provide 
Figure 4. CViT Annotation System.Cancer Informatics 2007:5 6
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the means by which CViT developers will collab-
orate, track, control and backup the source code 
for their evolving models over a long period of 
time. The ViewCVS open source system or some-
thing similar will be used to provide a World-
wide-web browser based interface into the DMR 
along with the direct CVS connections over the 
internet. The system will include all the appro-
priate security mechanisms to secure access to 
the source code system for either reading or 
writing as appropriate to the collaboration. In 
addition to CVS, the DMR will establish obvious 
Life Science Identiﬁ  er (LSID) name mappings 
to all source code ﬁ  les and modules. A LSID 
Resolver (Clark et al. 2004; Martin et al. 2005) 
will be established for the DMR. Every version 
of every source code ﬁ  le and module in the DMR 
will always have a unique name in its own LSID. 
The combination of CVS source code control 
and LSID technologies will allow CViT model 
developers to have a means (the LSID name) to 
know exactly which source code ﬁ  le version and 
supporting code libraries were used for any 
particular model execution run. When necessary 
they will be able to use this unique identiﬁ  er to 
annotate, comment, or make unambiguous refer-
ence to these code modules in emails or research 
papers. 
We note in this context that any model descrip-
tion consists not only of the algorithm, its code 
implementation and, if available, its markup 
language representation (see below), but also of, 
for instance, related experimental data, simulation 
results, visualizations and manuscripts (Figure 6). 
Researchers using the SLRP system to track their 
modeling will automatically create and store 
Figure 5. Knowledge Integrated Modeling. Employing SLRP annotated data (e.g. from PubMed listed manuscripts; top left) are captured 
and used as model input parameters (top right). Deploying the code (language editing perspective, bottom right) to a high-performance 
compute environment yields in silico results that can then be compared with experimental data such as the microscopy images of tumors 
cultured in vitro (bottom left), or back to data published in the literature. This feedback allows continuous reﬁ  nement of the (DMR-archived) 
algorithm(s) and spurs design and development of experiments. Cancer Informatics 2007:5 7
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semantic links to the inputs and output of any 
particular model run, along with LSID references 
to the actual source code modules that were 
executed for any particular simulation execution 
run. The system will automatically document and 
make directly accessible the knowledge required 
to exactly reproduce a digital experiment without 
fear that the an incorrect version of the source code 
or input parameter data is being used.
Usage of CViT’s DMR content by participating 
investigators and their institutions will be enabled 
through an already posted open source license that 
is approved by the National Cancer Institute and 
in compliance with guidelines put forward by the 
Cancer Biomedical Informatics Grid, caBIG. Close 
interaction with caBIG is planned and will likely 
include caBIG standards compliant web-service to 
both use and provide data and access to high-
performance computing as well as specialized 
analysis algorithms. Finally, more work may be 
required at a later stage on the representation level 
if the models in CViT’s repository are to be 
integrated with those in other non-cancer focused 
digital repositories. Examples for such model 
representations include CellML (URL: http://www.
cellml.org/; its repository can be accessed at URL: 
http://www.cellml.org/models) which has already 
found use in the larger biomedical modeling 
community. Since CellML includes MathML, 
equations are straightforward to add. Additionally, 
the RDF section of CellML appears to be adaptable 
to describe other model parameters and would 
potentially integrate well with CViT’s overall 
underlying system platform that is based on RDF 
Figure 6. Digital Model Repository (DMR). Shown are three ‘Biologist Workbench’ views of data in the DMR. The ﬁ  rst image (top left) 
depicts an actual model instance, with links to the model artifacts, experimental data, source code, abstract representation (equations), 
related literature, annotation and, of course, the results, which may include biomedical images, video-microscopy and computer simulation 
movie. The second image (top right) shows how a user may choose to view the key module to which the model belongs whereas the third 
image (bottom) visually describes the semantic inter-relationship links between data elements in series of models.Cancer Informatics 2007:5 8
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as mentioned earlier. Another alternative is SBML 
(URL:http://sbml.org/index.psp; used e.g. by the 
repository of the European Bioinformatics Institute 
(URL:http://www.ebi.ac.uk/biomodels/)), which, 
although focused primarily on the biochemical 
pathway level, has however more libraries and 
parsers available and has been implemented in 
many biological modeling tools. 
Conclusion
The new paradigm of systems biology holds great 
promise for progress, from biomedical basic science 
(e.g. Kitano, 2002) to drug discovery (e.g. Hood and 
Perlmutter, 2004), and therefore in particular for 
cancer research (Coffey, 1998; Hornberg et al. 2006; 
Khalil and Hill, 2005; Waliszewski et al. 1998). 
Integrative cancer systems biology is built on the 
premise that a better understanding of the complexity 
of tumorigenesis requires design, development and 
implementation of novel, data-driven in silico 
models that account for the multi-scaled processes 
involved. However, cancer modeling algorithms are 
usually developed in a non-standardized fashion, 
often very speciﬁ  c in addressing a particular problem 
of interest, thus commonly lack widespread distribu-
tion, therefore acceptance in and feedback from 
experimentalists and clinicians. While one must 
concede that currently there is no perfect cancer 
model available or in sight, this fact all the more 
emphasizes the need of sharing and comparing avail-
able models as well as the data that went into them 
or are derived from them, thus for archiving algo-
rithms just as much as for exchanging concepts and 
results. It is here where CViT will make a difference. 
Its growing international group of investigators not 
only represents already an unparalleled level of 
expertise, it also allows for rapid dissemination of 
information relevant to the ﬁ  eld using the tools made 
available at CViT.org. The technologies CViT 
currently develops, speciﬁ  cally its semantic layered 
research platform with its digital model repository 
and knowledge integrated modeling workﬂ  ow 
address critical needs of the community and thus 
undoubtedly will help advance the ﬁ  eld of integrative 
cancer biology also beyond the current scope of 
NCI’s ICB program. All this creates a cutting edge 
environment that can make CViT’s long term vision 
for multi-scale cancer systems biology research a 
reality: i.e. the development a module-based cancer 
modeling tool-kit that can be speciﬁ  ed as need be in 
support of personalized medicine.
Acknowledgements
This work has been supported by NIH grant CA 
113004 and by the Harvard-MIT (HST) Athinoula 
A. Martinos Center for Biomedical Imaging and 
the Department of Radiology at Massachusetts 
General Hospital.
References
Araujo, R.P., Petricoin, E.F. and Liotta, L.A. 2005. A mathematical model 
of combination therapy using EGFR signaling network. Biosystems, 
80:57–69.
Athale, C., Mansury, Y. and Deisboeck, T.S. 2005. Simulating the impact 
of a molecular ‘decision-process’ on cellular phenotype and multicel-
lular patterns in brain tumors. J. theor. Biol., 233:469–481.
Athale, C.A. and Deisboeck, T.S. 2006. The effects of EGF-receptor density 
on multiscale tumor growth patterns. J. theor. Biol., 238:771–779. 
Bertalanffy v., L. 1968. General Systems Theory. George Braziller, New 
York, NY.
Clark, T., Martin, S. and Liefeld, T. 2004. Globally distributed object iden-
tiﬁ  cation for biological knowledgebases. Brief Bioinform., 5:59–70.
Coffey, D.S. 1998. Self-organization, complexity and chaos: The new biol-
ogy for medicine. Mat. Med., 4:882–885.
Deisboeck, T.S. and Kresh, J.Y. (eds). 2006. Complex Systems Science in 
Biomedicine. Springer, New York, NY.
Hood, L. and Perlmutter, R.M. 2004. The impact of systems approaches on bio-
logical problems in drug discovery. Nat. Biotechnol., 22:1215–1217.
Hornberg, J.J., Bruggeman, F.J., Westerhoff, H.V. and Lankelma, J. 2006. 
Cancer: a Systems Biology disease. Biosystems, 83:81–90. 
Ideker, T., Galitski, T. and Hood, L. 2001. A new approach to decoding life: 
systems biology. Annu. Rev. Genomics Hum. Genet., 2:343–372. 
Kauffman, S.A. 1993. The Origins of Order. Oxford University Press, New 
York, NY. 
Khalil, I.G. and Hill, C. 2005. Systems biology for cancer. Curr. Opin. 
Oncol., 17:44–48. 
Kholodenko, B.N., Demin, O.V., Moehren, G. and Hoek, J.B. 1999. Quan-
tiﬁ  cation of short term signaling by the epidermal growth factor 
receptor. J. Biol. Chem., 274:30169–30181.
Kitano, H. 2002. Systems Biology: A brief overview. Science, 295:1662–
1664. 
Mansury, Y. and Deisboeck, T.S. 2003. The impact of ‘search precision’ in 
an agent-based tumor model. J. theor. Biol., 224:325–337.
Mansury, Y. and Deisboeck, T.S. 2004. Simulating the time series of a 
selected gene expression proﬁ  le in an agent-based tumor model. 
Physica. D., 196:193–204. 
Martin, S., Hohman M.M. and Liefeld, T. 2005. The impact of Life Science 
Identiﬁ  er on informatics data. Drug Discov. Today, 10:1566–1572.
Neumann, E. 2005. A life science Semantic Web: Are we there yet? Sci. 
STKE, 283:22.
Waliszewski, P., Molski, M. and Konarski, J. 1998. On the holistic approach 
in cellular and cancer biology: nonlinearity, complexity and quasi-
determinism of the dynamic cellular network. J. Surg. Oncol., 
68:70–78. 
Yeger-Lotem, E., Sattath, S., Kashtan, N., Itzkovitz, S., Milo, Pinter, R.Y., 
Alon, U. and Margalit, H. 2004. Network motifs in integrated 
cellular networks of transcription–regulation and protein–protein 
interaction. Proc. Natl. Acad. Sci. U.S.A.,101:5934–5939. 
Zhang, L., Athale, C.A. and Deisboeck, T.S. 2007. Development of a three-
dimensional multiscale agent-based tumor model: simulating 
gene-protein interaction proﬁ  les, cell phenotypes & multicellular 
patterns in brain cancer. J. theor. Biol., 244:96–107. 